Tesla (TSLA) › Analysis

Tesla (TSLA) stock analysis, December 29, 2025: TSLA breaks $480 support after Morgan Stanley's $425 target

Published December 29, 2025 · TSLA chart, levels and live analysis

Key Updates

Tesla shares declined -3.53% to $466.73 since the December 23rd report, breaking below the critical $480 support level and marking the weakest close since early December. The pullback follows Morgan Stanley's significant downgrade to Equal-Weight with a $425 price target, representing the most bearish call from a major Wall Street firm in over two years. This retreat extends the post-record high correction, with shares now trading 4.7% below the December 17th all-time high of $489.88. The deterioration in sentiment is compounded by regulatory scrutiny from California's DMV regarding deceptive marketing practices and Michael Burry's renewed short position, creating a confluence of headwinds that challenge the robotaxi-driven valuation premium.

Current Trend

Tesla's YTD performance of +15.57% significantly underperforms the broader market, with shares lagging the S&P 500 despite the company's $1.63 trillion market capitalization. The stock established a new all-time high at $489.88 on December 17th but has since entered a corrective phase, declining -4.7% over the past 12 sessions. Near-term technical structure shows deterioration, with the 5-day decline of -3.01% accelerating from the 1-day loss of -1.78%, indicating building downward momentum. The $480 level, which provided support through mid-December, has now been breached, establishing a new resistance point. The 6-month gain of +44.22% and 1-month advance of +8.50% demonstrate the stock's volatile character, though recent price action suggests the robotaxi-driven rally may be exhausting. Critical support now resides at the $450-$460 zone, representing the early December consolidation area, while resistance has shifted to $480-$490.

Investment Thesis

The investment thesis centers on Tesla's transformation from an automotive manufacturer to an AI and autonomous vehicle platform, with the robotaxi network representing a potential $1 trillion value component according to Wedbush's Daniel Ives. This narrative supports the company's 190x forward earnings multiple, dramatically above traditional automakers (7x-11x) and tech giants like Google (28x). However, the thesis faces mounting structural challenges: core EV business deterioration with U.S. sales projected down 9% in 2025, EU sales declining 39% YoY through November, and China sales falling 9%. The robotaxi rollout significantly trails Musk's projections, with only 160 vehicles operating across Austin and San Francisco versus the year-end target of eight metropolitan areas. Full Self-Driving adoption remains at just 12% of customers as of Q3 2025, raising questions about revenue conversion. The $425 Morgan Stanley price target implies the AI premium has become disconnected from near-term fundamentals, while California's DMV ruling on deceptive marketing practices threatens both reputation and operations in Tesla's largest U.S. market.

Thesis Status

The investment thesis is under significant stress as reality diverges from projections. Morgan Stanley's downgrade from Overweight to Equal-Weight represents a critical inflection, as the firm had been Tesla's most prominent institutional supporter of the AI-driven valuation narrative. The analyst's acknowledgment that shares trade at 30x the firm's 2030 EBITDA estimate signals that even bulls recognize the valuation has outpaced fundamentals. Robotaxi deployment is materially behind schedule—160 vehicles versus the implied thousands needed for eight metropolitan areas—while the core automotive business deteriorates across all major markets. California's DMV ruling that Tesla engaged in deceptive marketing regarding Autopilot and Full Self-Driving capabilities directly undermines the autonomy narrative, with a potential 30-day sales suspension in the company's largest U.S. market representing tens of millions in lost revenue. Michael Burry's renewed short position, citing "ridiculous overvaluation" and 3.6% annual dilution, adds credibility to valuation concerns. The thesis requires rapid robotaxi scaling and FSD adoption acceleration, but regulatory hurdles, operational challenges, and consumer skepticism suggest a more protracted timeline than current valuations assume.

Key Drivers

Near-term catalysts are predominantly negative. Morgan Stanley's downgrade to Equal-Weight with a $425 price target removes a critical institutional support pillar and projects 6% downside from current levels. California's DMV ruling on deceptive marketing threatens a 30-day sales suspension in 2026, creating regulatory overhang and potential revenue disruption. Regulatory scrutiny across three continents over electric door safety, linked to at least 15 deaths, expands the compliance risk profile. Competitive pressure intensifies as European registrations plunge across key markets, with steep drops in France and Denmark despite new model launches. Michael Burry's renewed short position amplifies bearish sentiment, highlighting 3.6% annual dilution and Musk's compensation package concerns. Positive catalysts include driverless robotaxi testing in Austin, though the 31-vehicle fleet remains far below the 500-vehicle year-end target, and TD Cowen's $509 price target reaffirmation following positive RoboTaxi test experiences.

Technical Analysis

Tesla's technical structure has deteriorated from the December 17th all-time high of $489.88, with the current $466.73 level representing a -4.7% decline and establishing a lower high pattern. The breach of $480 support, which held through mid-December, shifts this level to resistance and opens downside toward the $450-$460 consolidation zone from early December. Momentum indicators show acceleration to the downside, with the 5-day decline of -3.01% expanding from the 1-day loss of -1.78%, suggesting sellers are gaining control. Volume characteristics during the decline indicate institutional distribution rather than retail panic, consistent with Morgan Stanley's downgrade impact. The 6-month chart shows an extended rally from $323 in late June to the December peak, representing a +51% advance that has now entered a corrective phase. Key resistance levels are $480 (former support), $490 (recent consolidation), and $498 (intraday high). Critical support resides at $460 (early December base), $450 (psychological level), and $425 (Morgan Stanley's price target). A failure to hold $460 would likely trigger accelerated selling toward the $425-$440 zone, while a recovery above $480 would suggest the correction has concluded. The YTD gain of +15.57% provides cushion, but the stock's 190x forward P/E multiple offers limited downside protection if sentiment continues deteriorating.

Bull Case

Bear Case

Get a message when the TSLA picture changes — the agent team watches the levels and the news for you.Create a free account

More TSLA analyses